{"disease":{"id":"papillary-thyroid-carcinoma","name":"Papillary thyroid carcinoma","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"lenvatinib","indication_name":"Papillary thyroid carcinoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lenvima","generic_name":"LENVATINIB","company_name":"Eisai","drug_phase":"marketed","molecular_target":"Proto-oncogene tyrosine-protein kinase receptor Ret","drug_class":"Kinase Inhibitor [EPC]","quality_score":75,"revenue":"1053.0","mechanism":"Lenvima works by blocking the activity of a specific protein called Ret, which is involved in the growth and spread of cancer cells."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06871956","title":"PMRA and Shapley-Based Machine Learning for Predicting Lymph Node Metastasis in Central Subregions of Clinically Node-Negative Papillary Thyroid Microcarcinoma: a Prospective Multicenter Validation and Development of a Web Calculator","phase":"","overall_status":"COMPLETED","enrollment_count":4882,"lead_sponsor_name":"First Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT07299318","title":"Multimodal Deep Learning for Lymph Node Metastasis in Thyroid Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3200,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT06725628","title":"Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid Carcinoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Tianhan Zhou","has_results":false},{"nct_id":"NCT06583057","title":"Multicenter Comparison of Thermal Ablation Versus Thyroid Lobectomy for Subcapsular Papillary Thyroid Microcarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT07249125","title":"Safety and Quality of Life of Three Treatment Strategies for Low-Risk Papillary Thyroid Microcarcinoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1630,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT06399159","title":"Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Nanchong Central Hospital","has_results":false},{"nct_id":"NCT04197960","title":"Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":973,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06623578","title":"Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC","phase":"NA","overall_status":"RECRUITING","enrollment_count":876,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT02834013","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07042984","title":"RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Fujian Medical University","has_results":false},{"nct_id":"NCT05962892","title":"A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06626581","title":"Iodine Status and Characteristics of Papillary Thyroid Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Shandong Provincial Hospital","has_results":false},{"nct_id":"NCT03037385","title":"Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":590,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT06971965","title":"Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":578,"lead_sponsor_name":"National Cancer Center, Korea","has_results":false},{"nct_id":"NCT02568267","title":"Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":534,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT06261190","title":"Active Surveillance for Low-risk Papillary Thyroid Carcinoma","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":499,"lead_sponsor_name":"National Cancer Center, Korea","has_results":false},{"nct_id":"NCT07054229","title":"Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhanced Ultrasound Combined With Genetic and Molecular Diagnostics: A Prospective Observational Study","phase":"","overall_status":"RECRUITING","enrollment_count":480,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT04624477","title":"Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":450,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT06439745","title":"More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated","phase":"","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06730893","title":"Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":310,"lead_sponsor_name":"National Cancer Center, Korea","has_results":false},{"nct_id":"NCT05932121","title":"Cross-sectional Case and Control Study on Quality of Life, Appearance and Functions in PTC Via Different Surgical Approach","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06333587","title":"Minimally Invasive Treatments of the Thyroid","phase":"","overall_status":"RECRUITING","enrollment_count":270,"lead_sponsor_name":"European Institute of Oncology","has_results":false},{"nct_id":"NCT06241092","title":"AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":256,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03808779","title":"A Multicenter Trial of Radiofrequency Ablation vs. Surgery as Treatment of Papillary Thyroid Microcarcinoma.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04336696","title":"Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0?","phase":"NA","overall_status":"UNKNOWN","enrollment_count":199,"lead_sponsor_name":"Bassem Mohamed Sieda","has_results":false},{"nct_id":"NCT05760690","title":"Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola","phase":"NA","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07391514","title":"Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"First Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT01208051","title":"Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06592755","title":"Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT07302672","title":"Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":108,"lead_sponsor_name":"Ming-an Yu","has_results":false},{"nct_id":"NCT03327636","title":"A Trial Comparing USG-HIFU vs AS in Management of Low-risk PTMC","phase":"NA","overall_status":"SUSPENDED","enrollment_count":103,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT03432299","title":"Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03411187","title":"Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Bo Wang,MD","has_results":false},{"nct_id":"NCT03454477","title":"Comparison Between Robotic, Endoscopic and Traditional Open Surgery in Thyroidectomy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Fujian Medical University","has_results":false},{"nct_id":"NCT05263141","title":"Retro-Auricular Single-Site Endoscopic to Papillary Thyroid Carcinoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04731467","title":"A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"Famewave Ltd.","has_results":false},{"nct_id":"NCT03753919","title":"Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":79,"lead_sponsor_name":"Grupo Espanol de Tumores Neuroendocrinos","has_results":true},{"nct_id":"NCT00381641","title":"Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT02393690","title":"Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":true},{"nct_id":"NCT02973997","title":"Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":true},{"nct_id":"NCT06901908","title":"Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis \"Suspicious for Papillary Thyroid Carcinoma\"","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04376203","title":"Microbiome and Papillary Thyroid Microcarcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University of Ioannina","has_results":false},{"nct_id":"NCT07062211","title":"Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":39,"lead_sponsor_name":"Superior University","has_results":false},{"nct_id":"NCT07536412","title":"Decision Aid Efficacy in Low Risk Thyroid Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":34,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT02152995","title":"Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":34,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06959641","title":"XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":33,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT04759911","title":"Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07506161","title":"Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas","phase":"","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Premier G Med Cardio Kft","has_results":false},{"nct_id":"NCT01811212","title":"Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04544111","title":"PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":19,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}